Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 2/20 | 1.00 |
| ▸ | F2 | P00734 | 1/20 | 0.65 |
| ▸ | HTR2A | P28223 | 1/20 | 0.50 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.50 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.48 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1878642 | 1.00 | DPP4 (1.00) | DPP4F2HTR2ATAAR1ADRA2A | |
| SCHEMBL2067094 | 1.00 | DPP4 (1.00) | DPP4F2HTR2ATAAR1ADRA2A | |
| SCHEMBL851654 | 1.00 | DPP4 (1.00) | DPP4F2HTR2ATAAR1ADRA2A | |
| SCHEMBL150159 | 1.00 | DPP4 (1.00) | DPP4F2HTR2ATAAR1ADRA2A | |
| SCHEMBL239938 | 1.00 | DPP4 (1.00) | DPP4F2HTR2ATAAR1ADRA2A | |
| Ammonia Solution, Strong SCHEMBL4410348 | 0.97 | DPP4 (0.93) | DPP4F2HTR2ATAAR1ADRA2A | |
| Hydrochloric Acid SCHEMBL9670481 | 0.97 | DPP4 (0.93) | DPP4F2HTR2ATAAR1ADRA2A | |
| Lithium SCHEMBL31260781 | 0.97 | DPP4 (0.93) | DPP4F2HTR2ATAAR1ADRA2A | |
| SCHEMBL10350027 | 0.97 | DPP4 (0.93) | DPP4F2HTR2ATAAR1ADRA2A | |
| SCHEMBL6743969 | 0.97 | DPP4 (0.93) | DPP4F2HTR2ATAAR1ADRA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 142 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115124491-A | Preparation method of cyclododecane oxide and cyclododecanone | 中国科学院上海有机化学研究所 | 2022-09-30 | — | — | CN | claimed |
| CN-109456471-B | Method for simultaneously synthesizing chiral polyester and retaining chiral terminal alkylene oxide | 大连理工大学 | 2021-02-19 | — | — | CN | claimed |
| CN-106543074-B | One-dimensional chirality Cu (II) chain complex of one kind and the preparation method and application thereof | 山东师范大学 | 2019-03-19 | — | — | CN | claimed |
| CN-106543074-A | A kind of one-dimensional chiral Cu (II) chain coordination compound and preparation method and application | 山东师范大学 | 2017-03-29 | — | — | CN | claimed |
| US-9353390-B2 | Genetically engineered microbes and methods for producing 4-hydroxycoumarin | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2016-05-31 | — | — | US | claimed |
| CN-103272648-B | Magnetic porous supported metallic chiral catalyst and application thereof | UNIV WENZHOU | 2015-01-28 | — | — | CN | claimed |
| US-20140370557-A1 | GENETICALLY ENGINEERED MICROBES AND METHODS FOR PRODUCING 4-HYDROXYCOUMARIN | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 2014-12-18 | — | — | US | claimed |
| CN-103272648-A | Magnetic porous supported metallic chiral catalyst and application thereof | UNIV WENZHOU | 2013-09-04 | — | — | CN | claimed |
| CN-101940951-B | Load-type chiral catalyst and application thereof in catalysis preparation of Fluoxetine intermediate | UNIV WENZHOU | 2012-06-20 | — | — | CN | claimed |
| CN-102228842-A | Supported iron-based chiral complex catalyst and preparation method and application thereof | UNIV WENZHOU | 2011-11-02 | — | — | CN | claimed |
| CN-101940951-A | Load-type chiral catalyst and application thereof in catalysis preparation of Fluoxetine intermediate | UNIV WENZHOU | 2011-01-12 | — | — | CN | claimed |
| US-20070259774-A1 | Enantioselective Phosphoramidite Compounds and Catalysts | YALE UNIVERSITY (US) | 2007-11-08 | — | — | US | claimed |
| EP-1745056-A4 | ENANTIOSELECTIVE PHOSPHORAMIDITE COMPOUNDS AND CATALYSTS | YALE UNIVERSITY CORP (US) | 2007-10-31 | — | — | EP | claimed |
| EP-1745056-A2 | ENANTIOSELECTIVE PHOSPHORAMIDITE COMPOUNDS AND CATALYSTS | Yale University Corporation (US) | 2007-01-24 | — | — | EP | claimed |
| US-20060199728-A1 | Enantioselective amination and etherification | YALE UNIVERSITY (US) | 2006-09-07 | — | — | US | claimed |
| WO-2005111050-A2 | ENANTIOSELECTIVE PHOSPHORAMIDITE COMPOUNDS AND CATALYSTS | YALE UNIVERSITY (US) | 2005-11-24 | — | — | WO | claimed |
| WO-2005077885-A1 | RUTHENIUM-CATALYZED HYDROAMINATION OF OLEFINS | YALE UNIVERSITY (US) | 2005-08-25 | — | — | WO | claimed |
| EP-3997082-B1 | PROCESS FOR THE SYNTHESIS OF NON-RACEMIC CYCLOHEXENES | BASF CORP (US) | 2026-04-15 | — | — | EP | disclosed |
| US-5352814-A | Optically active manganese complex | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 1994-10-04 | — | — | US | disclosed |
| EP-0535377-A2 | Optically active benzopyran compound, process for producing it and optically active manganese complex | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1993-04-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070259774-A1 | Enantioselective Phosphoramidite Compounds and Catalysts | AKR1C3, PCNA, AKR1C4 | DPP4 2730/4885F2 455/4885HTR2A 3816/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.